Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.)
|
|||
| Mailing Address: | P.O. Box 1570 Belleville, Ontario K8N 5J2 |
Head Office Address: | 231 Dundas Street East Belleville, Ontario K8N 1E2 |
| Contact Name: | Emmanuela Fleurandin | Principal Regulator: | Ontario |
| Business e-mail address: | emmanuela.fleurandin@telestatherapeutics.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 514 587-6148 | Reporting Jurisdictions: | Ceased Reporting |
| Fax Number: | Stock Exchange: | TSX | |
| Date of Formation: | Sep 1 1999 | Stock Symbol: | |
| Jurisdiction Where Formed: | Canada | Auditor: | Ernst & Young LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 09063 | Transfer Agent: | Canadian Stock Transfer Company |
| Financial Year-End: | Jun 30 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
